Big Pharma’s Cannabis Pill Is Killing People

Big Pharma's cannabis pill is killing people who take it

Big Pharma’s attempts to synthesise cannabis into an artificial pill form are not only failing, but killing people in the process. 

Medical research shows that our bodies are able to synthesise endocannabinoids naturally. Endocannabinoids are the chemical compounds that activate the same receptors as delta-9-tetrahydrocannabinol (THC), the active component of marijuana. 

Big Pharma have attempted to patent this natural herb via a chemical alternative pill in order to cash in on the market. 

Trying to synthesis cannabis has been attempted before, as evidenced by Solvay Pharmaceuticals with its Marinol drug, and the results have proved fatal.

Pharmaceutical company Bial tested its cannabis pill ‘Biotrial’ – a synthetic ECS stimulant that replicated the effects of cannabis – and had to halt testing due to the death of one of the participants in the University Hospital of Rennes in France.

In the US cannabis is becoming legal in more and more states.  A recent survey taken by the Centre for Addictions Research of BC, found that 80 percent of Americans are trading in the ‘pills for pot’.

Even further research has found that this will result in a 25 percent decrease in death rates.

Perhaps Big Pharma will take note, and leave cannabis the way mother nature intended.

  • Dio Jones

    All about population control…

    Be a light shininginthedark

  • Lynn-no-duh

    There are numerous “active components” in cannabis. THC is the most psychoactive cannabinoid.

    The author suggests “perhaps Big Pharma will take note, and leave cannabis the way mother nature intended.”
    Big Pharma is definitely taking notice, but by no means does that mean they intend to leave cannabis natural – there’s no money in that. Hence the need for them to synthetically replicate it, as they continue to lobby for continued prohibition of this non-toxic, miraculous, plant. It’s prohibition is a crime against humanity.

    • sailorbill


  • Kuma

    The substance being trialled wasn’t a synthetic cannabinoid of any shape or form, rather it was an FAAH inhibitor. FAAH, or Fatty Acid Amide Hydrolase, is an enzyme that works to break down and suppress endogenous cannabinoids, otherwise known as endocannabinoids.

    Endocannabinoids are, in simple terms, the human body’s own form of internally produced cannabis-like compounds. These compounds regulate homeostasis and are vital for a healthy body and mind, endocannabinoid deficiency is thought to be responsible for various health issues.The endocannabinoid Anandamide, also known as the ‘bliss molecule’, is found in quantities in breast milk and has a molecular structure similar to that of THC derived from cannabis.

    Rather than administering a potentially dangerous experimental synthetic cannabinoid, they were trying to enhance existing cannabinoid signalling by allowing anandamide to accumulate. By prolonging the action of anandamide and other endocannabinoids, FAAH inhibitors have the potential to reduce anxiety, pain, and other neurological conditions.

    Cannabis is already proven efficacious in these fields, indeed it’s used safely every day by millions of people around the world for its medicinal and therapeutic benefits. Instead of blocking the natural degradation of our endocannabinoids with FAAH inhibitors, perhaps we should look at what has been done safely for thousands of years, supplementing our endocannabinoids with cannabis. At least then we can guarantee that patients will survive their treatment.